Company intelligence / Profile preview

Centese

Omaha, Nebraska, United Statescentese.com ↗

Ownership: Private
Development stage: Other

Overview

Centese has developed and commercialized Thoraguard, a self-cleaning, automated chest tube system designed to improve post-operative outcomes for patients recovering from cardiac and thoracic surgeries. The system provides precise digital monitoring of fluid drainage, automates clog clearance, reduces complications associated with traditional chest tubes, and improves workflow efficiency for clinical staff[2][3].

Therapeutic areas: Cardiovascular
Modalities: DeviceDigital health technology (for surgical drainage monitoring)
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Centese.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centese.

Explore the full profile